AeroVironment secured multiple U.S. government contracts in recent weeks, including a major Army award for unmanned aircraft systems and a prototype agreement for advanced programs. The company announced facility expansions in Ohio and Alabama, supported by government funding, to boost production capacity for drones and related technologies.
Regencell Bioscience Holdings Limited (RGC) shares plunged about 14% in the most recent completed session, dropping to roughly $12.01 from above $14.The sell-off intensified after a wave of law-firm announcements highlighting a pending securities class action and potential DOJ-related investigations into the company’s disclosures and valuation.
Alamos Gold Inc. shares are down about 12.00% in today’s session, trading near the low end of their intraday range. The drop comes alongside a pullback in gold miners after recent strength in the underlying gold price, prompting profit‑taking across the group.
Velo3D, Inc. (VELO) shares dropped approximately 17.00% in the latest trading session.
The decline appears driven by ongoing concerns about financial performance and liquidity.
Fiserv Small Cap ETF (FISN) plunged approximately 18.00% in the latest session.
The sharp drop appears driven by liquidity constraints and outsized moves in underlying small-cap holdings.
BTQ Technologies Corp. (BTQ) shares plunged approximately 21.00% in the latest trading session.
The sharp drop appears tied to profit-taking and volatility in quantum computing and emerging tech stocks.
NFLX fell -5.58% to $73.07 during regular trading hours from the prior close of $77.38. Primary catalyst was Netflix walking away from potential deals with Roku and Warner Bros.
SPCX declined -10.76% to approximately 165.09 during regular trading hours from the prior session close of 185.00. The move reflects post-IPO profit-taking following the stock's strong debut and subsequent rally. The primary catalyst was the company's announcement of its first-ever bond offering, launched just 10 days after its record-breaking $75 billion IPO, raising concerns about cash needs.
AVAV fell -8.46% to $155.27 during regular trading hours from a prior close of $169.61. The primary catalyst was the company's 8-K filing detailing a material financial restatement that overstated assets and equity while understating losses, alongside disclosure of a material weakness in internal controls.
AGI fell -14.53% to $31.06 during regular trading hours from the prior close of $36.34. The sharp decline followed Alamos Gold's operational update lowering Q2 2026 consolidated production guidance to 130,000–135,000 ounces due to seismic events, power outages, and lower grades at the Young-Davidson mine.
APGE surged +46.75% to $132.63 during regular market hours from a prior close of $90.38. Primary catalyst was AbbVie’s $10.9 billion cash acquisition announcement.
Shares of Space Exploration Technologies Corp. (SPCX) fell approximately 4.62% in premarket trading on Monday, June 22, 2026, extending the post-IPO pullback that began last week. The primary overnight catalyst is MSCI's CCC ESG rating — the lowest classification on its global scale — which was published ahead of the weekend and triggered an immediate selloff in after-hours trading Sunday night.
WDCX is surging approximately +10% in Monday premarket trading on June 22, 2026, reflecting a leveraged amplification of Western Digital's underlying share price movement. The primary catalyst is Western Digital's own premarket rally of roughly +5%, driven by investor anticipation surrounding the company's long-awaited SanDisk separation event scheduled for today, June 22.
Shares of Definium Therapeutics (DFTX) surged approximately 55% in premarket trading on Monday, June 22, 2026, following a landmark clinical data readout. The primary catalyst is a positive Phase 3 Emerge trial result for DT120 ODT — an LSD-based orally disintegrating tablet — which met its primary endpoint with high statistical significance (p<0.0001) in treating major depressive disorder.
Shares of Apogee Therapeutics (APGE) surged approximately 46% in premarket trading on Monday, June 22, 2026, following a confirmed acquisition announcement. AbbVie Inc. (ABBV) announced it will acquire Apogee Therapeutics for $10.9 billion in an all-cash transaction, offering $135.11 per share.
Shares of AngloGold Ashanti (AU) are trading approximately 6% lower in premarket hours on Monday, June 22, 2026, extending a multi-session pullback that began in mid-June. The primary catalyst is a sharp decline in spot gold prices — bullion shed roughly $53.70 per ounce overnight, revisiting one-week lows as investor risk appetite shifted.
Carnival Corporation is scheduled to report fiscal second-quarter 2026 results on June 23, 2026, before market open. Analysts expect earnings per share of $0.34 for the quarter ending May 31, 2026.
FedEx is scheduled to report fourth-quarter fiscal 2026 results on June 23, 2026, after market close. Analysts project adjusted earnings per share of approximately $5.91 to $5.94.
Outdoor Holding Company is scheduled to report fiscal Q4 2026 results before market open on June 22, 2026. Analysts currently model EPS of approximately ($0.015) on revenue of about $12.24 million for the quarter.
Simulations Plus (SLP) surged approximately 29% over the last 30 days, climbing from $14.10 on May 19 to $18.24 by June 18, 2026. The definitive acquisition agreement with Altaris for $18.50 per share in cash, announced in mid-June, served as the primary catalyst for the sharp upward move.